Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial

The optimal blood pressure (BP) goal in patients with diabetes mellitus remains controversial. We examined whether benefits and risks of intensified antihypertensive therapy in diabetes mellitus are influenced by either baseline BP or cardiovascular disease (CVD) risk. We studied 10 948 people with...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Rahman, F, McEvoy, J, Ohkuma, T, Marre, M, Hamet, P, Harrap, S, Mancia, G, Rodgers, A, Selvin, E, Williams, B, Muntner, P, Chalmers, J, Woodward, M
Μορφή:	Journal article
Έκδοση:	American Heart Association 2019

Παρόμοια τεκμήρια

Side-effects and tolerability of combination blood pressure lowering according to blood pressure levels – an analysis of the PROGRESS and ADVANCE trials
ανά: Atkins, A, κ.ά.
Έκδοση: (2017)

Response of 1,5‐anhydroglucitol level to intensive glucose‐ and blood‐pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial
ανά: Selvin, E, κ.ά.
Έκδοση: (2019)

Prognostic value of variability in systolic blood pressure related to vascular events and premature death in type 2 diabetes mellitus: The ADVANCE-ON study
ανά: Ohkuma, T, κ.ά.
Έκδοση: (2017)

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials
ανά: Czernichow, S, κ.ά.
Έκδοση: (2011)

Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
ανά: Kengne, A, κ.ά.
Έκδοση: (2009)

Lowering blood pressure reduces renal events in type 2 diabetes.
ανά: de Galan, B, κ.ά.
Έκδοση: (2009)

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
ανά: Zoungas, S, κ.ά.
Έκδοση: (2009)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.
ανά: Hata, J, κ.ά.
Έκδοση: (2013)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The advance trial
ανά: Hata, J, κ.ά.
Έκδοση: (2013)

Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study
ανά: Rådholm, K, κ.ά.
Έκδοση: (2018)

Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus: the ADVANCE trial
ανά: Ohkuma, T, κ.ά.
Έκδοση: (2018)

Effects of blood pressure lowering on intracranial and extracranial bleeding in patients on antithrombotic therapy: the PROGRESS trial.
ανά: Arima, H, κ.ά.
Έκδοση: (2012)

Cumulative in-trial and post-trial effects of blood pressure and lipid lowering: systematic review and meta-analysis.
ανά: Hirakawa, Y, κ.ά.
Έκδοση: (2017)

Impact of baseline systolic blood pressure on visit-to-visit blood pressure variability: the Kailuan study
ανά: Wang A, κ.ά.
Έκδοση: (2016-08-01)

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data
ανά: Karmali, K, κ.ά.
Έκδοση: (2018)

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
ανά: Patel, A, κ.ά.
Έκδοση: (2008)

Reduced blood pressure after smooth muscle EFNB2 deletion and the potential association of EFNB2 mutation with human hypertension risk
ανά: Woodward, M, κ.ά.
Έκδοση: (2016)

Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks
ανά: Mehlum, MH, κ.ά.
Έκδοση: (2018)

Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysis
ανά: Lv, J, κ.ά.
Έκδοση: (2012)

Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial
ανά: Ohkuma, T, κ.ά.
Έκδοση: (2019)

Olfactory receptor 78 modulates renin but not baseline blood pressure
ανά: Brian G. Poll, κ.ά.
Έκδοση: (2021-09-01)

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
ανά: Kamel Mohammedi, κ.ά.
Έκδοση: (2021-01-01)

P.090 BASELINE PULSE WAVE VELOCITY IS AN INDEPENDENT PREDICTOR OF THE BLOOD PRESSURE REDUCTION AND EFFECTIVE BLOOD PRESSURE CONTROL: THE REASON STUDY
ανά: A.D. Protogerou, κ.ά.
Έκδοση: (2007-08-01)

Potential impact of systematic and random errors in blood pressure measurement on the prevalence of high office blood pressure in the United States
ανά: Swati Sakhuja, κ.ά.
Έκδοση: (2022-03-01)

Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system.
ανά: Turnbull, F, κ.ά.
Έκδοση: (2007)

A comparison of the 2017 American College of Cardiology/American Heart Association Blood Pressure guideline and the 2017 American Diabetes Association Diabetes and Hypertension position statement for U.S. adults with diabetes
ανά: Muntner, P, κ.ά.
Έκδοση: (2018)

Association of baseline serum cholesterol with benefits of intensive blood pressure control
ανά: Xiaoqi Wang, κ.ά.
Έκδοση: (2023-09-01)

A comparison of the 2017 American College of Cardiology/American Heart Association Blood Pressure guideline and the 2017 American Diabetes Association Diabetes and Hypertension position statement for U.S. adults with diabetes
ανά: Muntner, P, κ.ά.
Έκδοση: (2018)

Ambulatory Blood Pressure Monitoring and Circadian Rhythm of Blood Pressure in Diabetes Mellitus
ανά: Elena Matteucci, κ.ά.
Έκδοση: (2013-10-01)

Importance of mean blood pressure and blood pressure variability for the effect of valsartan versus amlodipine on cardiovascular events and death
ανά: Mehlum, MH, κ.ά.
Έκδοση: (2018)

The Microbiome and Blood Pressure: Can Microbes Regulate Our Blood Pressure?
ανά: Souhaila Al Khodor, κ.ά.
Έκδοση: (2017-06-01)

Mortality and Disability According to Baseline Blood Pressure in Acute Ischemic Stroke Patients Treated by Thrombectomy: A Collaborative Pooled Analysis
ανά: Benjamin Maïer, κ.ά.
Έκδοση: (2017-10-01)

Mortality and Disability According to Baseline Blood Pressure in Acute Ischemic Stroke Patients Treated by Thrombectomy: A Collaborative Pooled Analysis
Έκδοση: (2017-12-01)

Effects of salt substitute on home blood pressure differs according to age and degree of blood pressure in hypertensive patients and their families
ανά: Jihong Hu, κ.ά.
Έκδοση: (2018-10-01)

Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials
ανά: Hua, X, κ.ά.
Έκδοση: (2020)

Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis.
ανά: Glasziou, P, κ.ά.
Έκδοση: (2010)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
ανά: Woodward, M, κ.ά.
Έκδοση: (2016)

Baseline blood pressure and development of cardiotoxicity in patients treated with anthracyclines: A systematic review
ανά: Laura J. Philip, κ.ά.
Έκδοση: (2022-12-01)

Reaching an ACCORD on Glycemia and Systolic Blood Pressure Targets in Type 2 Diabetes Mellitus
ανά: Thomas M. MacDonald, κ.ά.
Έκδοση: (2018-09-01)

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.
ανά: Patel, A, κ.ά.
Έκδοση: (2007)